Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Gliosarcoma 31Glioblastoma 30Sarcoma 22Rhabdomyosarcoma 8Brain Neoplasms 7Astrocytoma 7Central Nervous System Neoplasms 6Melanoma 4Liposarcoma 4Histiocytoma, Malignant Fibrous 4Glioma 4Bone Neoplasms 4Sarcoma, Synovial 3Sarcoma, Ewing 3Rhabdomyosarcoma, Embryonal 3Osteosarcoma 3Neoplasm Metastasis 3Leiomyosarcoma 3Breast Neoplasms 3Rhabdomyosarcoma, Alveolar 2Prostatic Neoplasms 2Pain 2Ovarian Neoplasms 2Oligodendroglioma 2Neurofibrosarcoma 2Neoplasms 2Medulloblastoma 2Dermatofibrosarcoma 2Carcinoma, Merkel Cell 2Vulvar Neoplasms 1

Interventions

Temozolomide 1Radiotherapy 1Radiation 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Diseases × Radiation × Sarcoma × Clear all
NCT00895960 2018-11-08

Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma

M.D. Anderson Cancer Center

Phase 1 Terminated
16 enrolled
CNSSarcoma

Brain Diseases, Central Nervous System Diseases, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡